Senior Director, Authorized Treatment Center (ATC) Cell Therapy Operations

About   Iovance Biotherapeutics, Inc.   Iovance Biotherapeutics , Inc.  is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The  Iovance TIL platform  spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit  www.iovance.com . Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners. Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on  www.iovance.com . Overview The Senior Director, Authorized Treatment Center (ATC) Cell Therapy Operations leads the strategy, team, and operational performance of Iovance’s treatment-center network. This role oversees center authorization, readiness, ongoing support, and network growth to support patient access and reliable treatment coordination. Working with treatment-center leaders and internal partners, the Senior Director sets operational standards, manages resources and risks, and prepares the network for new indications and changing business needs. Essential Functions and Responsibilities • Lead and develop the ATC Operations team, with clear responsibilities, staffing plans, workload allocation, coaching, and succession planning. • Set the ATC network strategy, multiyear plan, and annual objectives based on patient access, geographic coverage, referral demand, center capacity, performance, and anticipated growth. • Oversee center authorization, onboarding, readiness, ongoing support, monitoring, remediation, reauthorization, and deactivation, as applicable; ensure required milestones and documentation are completed. • Provide operational leadership across tumor procurement, order intake, logistics, manufacturing coordination, and treatment readiness, including chain of identity and custody and supporting systems. Coordinate responsibilities with Commercial, Quality, Manufacturing, Supply Chain, Regulatory, Medical, and treatment-center teams. • Lead operational reviews with company and treatment-center leaders; communicate performance, capacity, risks, and priorities, resolve issues across functions, and track decisions and actions to completion. • Maintain ATC operating standards and training requirements that reflect approved labeling, regulatory commitments, applicable guidance, and company policies, in partnership with Quality, Regulatory, and Medical. • Set performance measures for center readiness, capacity, throughput, turnaround times, support demand, compliance, and center experience; use results and center feedback to prioritize improvements. • Simplify and standardize processes, systems, tools, communications, and support according to center volume, complexity, experience, and risk. • Establish escalation procedures and response expectations for operational incidents and recurring issues. Partner with Quality on investig